A$-reduced amiA mutants of Streptococcus pneumoniae were shown to be resistant to the positively charged antitumoral drugs 2-N-methylellipticinium (NME) and 2-N-methyl-9hydroxyellipticinium (NMHE). Conversely, mutants selected for their resistance to NMHE were mapped within the amiA locus and exhibited the pleiotropic AmiA-phenotype. This shows that A$ is a critical parameter in determining resistance to these drugs in S. pneumoniae and suggests that they are accumulated within this bacterium in response to A$. As a consequence NME and NMHE appear to be valuable tools for selecting A$-reduced mutants in S. pneumoniae.
INTRODUCTION
The antitumoral drugs derived from pyridocarbazole, viz. ellipticine and its derivatives 9hydroxyellipticine, 2-N-methylellipticinium (NME) and 2-N-methyl-9-hydroxyellipticinium (NMHE), have been shown to interact with DNA (Festy et al., 1971 ; Le Pecq et al., 1974) as well as with model (Lempereur et al., 1984; Terck et al., 1983) and natural (Terck et al., 1983) membranes in uitro. Their mechanism of action in both eukaryotic and prokaryotic systems is, however, poorly understood. NME and NMHE are amphiphilic and cationic; therefore a possibility could be that they penetrate cells in response to the electric transmembrane potential, A$*
The chemiosmotic hypothesis predicts that, for cationic substrates such as NME or NMHE, transport can be driven by A$ (interior negative). If this is the case, A$-reduced mutants should be resistant to NME and NMHE and, conversely, among NME-and NMHE-resistant mutants one would expect to find A$-reduced strains. The amiA mutants of the Gram-positive bacterium Streptococcus pneumoniae selected for their resistance to methotrexate (MTX) have been characterized as A$-reduced mutants . These mutants thus constitute a valuable tool for determining the effect of A$ on the transport and the toxicity of NME and NMHE. 
Table 1. MICs of ellipticine and its derivatives 9-hydroxyellipticine, NME and NMHE for the wild-type and amiA9 strains
The data represent the minimal concentrations which do not allow colony formation on plates after 18 h incubation at 37 "C.
Ellipticine 7.5 x 10-6 7.5 x 10-6 NME 1.5 x 10-5 1.5 x 10-5 NMHE 5 x 10-4 3 x 10-3 9-Hydroxyellipticine 1.5 x 1.5 x Mapping experiments. These were done according to . Mutants sensitive to an imbalance in the concentrations of the three branched amino acids, valine, leucine and isoleucine (sensitive to an excess of isoleucine, Isos) were transformed, either by chimaeric plasmids bearing wild-type sequences of the amiA locus,. or by DNA isolated from other mutants with the same phenotype. Wild-type recombinants, resistant to an excess of isoleucine (IsoR), were selected on plates. Recombination frequency was calculated by reference to the mutation Str42 (Sicard, 1964) . One recombination unit represents 30 DNA base pairs (Claverys et al., 1979) .
Chemicals. Ellipticine and 9-hydroxyellipticine were synthesized and purified by P. Lecointe (Centre de Pharmacologie et Toxicologie Fondamentales du CNRS, Toulouse, France). NME and NMHE (Fig. 1 ) were synthesized and purified by J. Chenu (SANOFI and Centre de Pharmacologie et Toxicologie Fondamentales du CNRS, Toulouse, France). Methotrexate (MTX) was kindly provided by Specia (16 rue Clisson, 75646 Paris, France).
RESULTS

SpeciJic resistance of the A$-reduced amiA9 mutant of S. pneumoniae to the positively charged derivatives of ellipticine, NME and NMHE
The MICs of ellipticine, 9-hydroxyellipticine, NME and NHME were determined for the nonsense mutant amiA9 (Gasc et al., 1979) and the wild-type strain (Table 1) . For both strains the quaternary ammonium derivatives (NME and NMHE) were less inhibitory than ellipticine and 9-hydroxyellipticine. Similar results have been obtained in eukaryotic systems (Paoletti et al., 1979) . Mutant amiA9, which has a reduced A$ compared with the wild-type , was selectively resistant to NME and NMHE (Table 1 ). This could reflect the Table 2 
. Characteristics of NMHE-resistant mutants compared with the wild-type and amiA9 strains
Max. concn (M) allowing 100% colony formation NO. of NMHE-L 1 NMHE NME Isolewinel resistant mutants MTX -W ild-type 5 x 10-7 2.5 x 10-4 7.5 x 10-6 2 x 10-2 amiA9 5 x 10-6 2 x 10-3 2 x 10-4 Group I 13 5 x 10-6 3 x 10-3 2 x 10-4 10-3 Group I1
15 5 x 10-7 3 x 10-3 2 x 10-4 2 x 10-2 involvement in the resistance mechanism of a decreased drug uptake in response to a decreased A+. Indeed, NMHE is mutagenic for S. pneumoniae (A. M. Sicard, personal communication), implying that the drug penetrates this bacterium. This is reminiscent of data presented by Charcosset et al. (1984) which showed that NME uptake by L1210 cells depended on A+. Interestingly, amiA mutants are also resistant to another antitumoral drug, MTX, which is a folate analogue (Trombe & Sicard, 1975; Trombe et al., 1979 . We therefore determined whether resistance to NME and to NMHE, which was observed for the MTX-resistant amiA9 strain, was related to folate analogue resistance in general. Isogenic MTX-resistant strains bearing mutations in the different genes involved in folate analogue resistance, i.e. dihydrofolate reductase (Sirotnak et al., 1964; Trombe & Sicard, 1975) , thymidilate synthase (Friedman & Ravin, 1972) or amiA (Trombe & Sicard, 1975; Trombe et al., 1979 , were tested for their resistance to NME and NMHE. The results obtained (not shown) indicated that resistance to NME and NMHE was not correlated with MTX resistance in general but was specific to the amiA mutants. Indeed all amiA mutants tested, including point mutations (amiA9, amiA25, amiA5, amiA19, amiA24 and amiAJ) , and deletions (amiA502 and amiA504) (Claverys et al., 1980) , which cover the entire locus (Fig. 2) , were resistant to NME and NMHE (not shown).
Isolation of NMHE-resistant mutants
To determine whether mutants selected for resistance to NMHE also exhibited the AmiAphenotype, i.e. MTX resistance and sensitivity to an imbalance in the branched amino acids valine, leucine and isoleucine , 28 spontaneous, independent NMHEresistant mutants isolated from the wild-type parent were analysed. All these mutants were as sensitive as the amiA9 mutant to the four ellipticine derivatives tested (Table 2) . These mutants formed two groups with respect to their resistance to MTX and sensitivity to an imbalance in branched amino acids. The results in Table 2 show that 13 of the 28 NMHE-resistant mutants were also MTX-resistant and were as sensitive to an imbalance in branched amino acids as the amiA9 mutant (group I), while the others, like the wild-type strain, were MTX-sensitive and isoleucine-resistant (group 11). In addition, NMHE resistance and MTX resistance of the group I mutants were both transferred by a single transformation event. This suggests that both characters are the result of a single mutation.
Mapping of the pleiotropic NMHE-resistant mutants within the amiA locus
To localize the group I mutations described above we transformed each strain with a chimaeric plasmid derived from pBR325 carrying a 5.7 kb PstIIEcoRI fragment belonging to the wild-type amiA locus (Mkjean et al., 1981) (Fig. 2) . All but three strains gave wild-type recombinants resistant to an imbalance in branched amino acids. This suggests that all the NMHE-resistant mutants belonging to group I, except these three, lie within this restriction fragment. The mutations were then localized more precisely with plasmids bearing subrestriction fragments. Nine out of a total of ten mutations were located within a 1.8 kb EcoRIIEcoRI fragment, the A fragment (Fig. 2) ; one was within a 1.8 kb HindIIIIEcoRI fragment to the right (Fig. 2) . The three mutants which did not recombine with the 5.7 kb PstIIEcoRI fragment were crossed with several mutants bearing point mutations which lie outside that fragment. The results (Table 3) show that these three mutants are linked to the mutation amiA142 located near a PstI site (Vasseghi & Claverys, 1983) on the left of the locus (Fig. 2) . Recombination frequencies (Table 3) imply that the four mutations amiA142, amiAllOl, amiA1109 and amiAIII0, which are external to the PstIIEcoRI fragment, define a fragment of about 0.15 kb. Therefore mutants selected for their NMHE resistance, belonging to group I, are amiA mutants. We have previously shown that the high MTX resistance of the amiA mutants could not be entirely explained by a decreased uptake of the drug resulting from their reduced A+ (Trombe, 1985) . It appears, rather, that the MTX resistance of the amiA mutants is correlated with the resistance of their membrane to hyperpolarization by MTX . Therefore, the amiA function is involved in A+-generation and in the response of the cytoplasmic membrane to MTX . Interestingly, the distribution of mutations selected using NMHE is quite different from those selected using MTX (Fig. 2 ). NMHE may thus constitute a tool for the preferential selection of mutants in specific regions of the amiA locus. It is possible that these regions code for domains in a protein or for polypeptides specifically involved in the generation of A+.
DISCUSSION
In the present report we have investigated the role of A+ in resistance to antitumoral drugs derived from ellipticine, using S. pneumoniae as a model system.
The A+-reduced amiA mutants of S . pneumoniae were selectively resistant to the positively charged derivatives of ellipticine NME and NMHE, but were as sensitive to ellipticine and 9-hydroxyellipticine as the wild-type parent (Tables 1 and 2 ). In addition, a set of NME-and NMHE-resistant mutants exhibited the same phenotype as the amiA mutants (Table 2 ) and mapped within the amiA locus (Fig. 2) . This shows that A+ is a critical parameter for NME and NMHE inhibition of S . pneumoniae growth, and suggests that IP: 54.70.40.11
On: Sat, 29 Dec 2018 04:33:03 A@-mutation and antitumoral drug resistance 2641 A@-driven transport of NME and NMHE is required for these compounds to have an effect.
Indeed, experiments with [3H]NMHE demonstrate a strong accumulation in wild-type cells and significantly less accumulation in the mutants (unpublished results). NME and NMHE have been shown to interact both with DNA (Festy et al.,, 1971; Le Pecq et al., 1974) and with membrane lipids (Lempereur et al., 1984; TercC et al., 1983) in uitro. Indeed, NMHE is mutagenic for S. pneumoniae (A. M. Sicard, personal communication), suggesting interaction with DNA in uiuo. Such an interaction has been demonstrated in Salmonella typhimurium using the fluorescent ellipticine derivative Val-NMHE (RenC et al., 1985) . Experiments are in progress with our model system to determine whether other targets for these compounds exist in vivo. In any case, the results in this report show that NME and NMHE constitute valuable tools to screen A@-reduced mutants of S. pneumoniae.
